Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nonsense Mutation Readthrough (None)
- Target
- None
- Molecular classification
- Other
01
Overview
Nonsense mutation readthrough refers to the process by which the cellular translation machinery bypasses a premature termination codon (PTC) caused by a nonsense mutation in mRNA, allowing for the synthesis of full-length, potentially functional proteins instead of truncated, nonfunctional ones. It is being explored as a therapeutic strategy for genetic diseases caused by PTCs.
02
Mechanism of action
Inducing ribosomes to bypass premature termination codons (PTCs) and continue translation until reaching the natural stop codon; suppressing nonsense-mediated mRNA decay (NMD).
03
Biological functions
Protein synthesismRNA translationGene expression
04
Disease associations
Genetic disorders caused by nonsense mutationsDuchenne muscular dystrophyCystic fibrosisSpinal muscular atrophyCancerMetabolic diseasesNeurologic disorders
05
Safety considerations
Off-target effects (ignoring normal stop codons)Toxicity associated with some TRIDsVariable efficacy depending on sequence context around PTC
06
Interacting drugs
Aminoglycoside antibiotics
2 more in the full profile.
Beyond the preview
Go deeper on Nonsense Mutation Readthrough (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nonsense Mutation Readthrough (None).